2022
DOI: 10.1007/s00284-022-02990-7
|View full text |Cite
|
Sign up to set email alerts
|

Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 96 publications
0
2
0
Order By: Relevance
“…A similar emphasis on chemicals is observed in research exploring the interaction between microbes and cancer, specifically focusing on secondary metabolites produced by Actinobacteria and Streptomyces spp. These metabolites, which include polyphenols, indolocarbazoles, anthracyclines, halogenated compounds, polyketides, anthracenes, and alkaloids, form the foundation of traditional chemotherapy drugs like doxorubicin, mithramycin, and mitomycin C ( 86 ).…”
Section: Plant Medicine: the Plant Microbiomementioning
confidence: 99%
“…A similar emphasis on chemicals is observed in research exploring the interaction between microbes and cancer, specifically focusing on secondary metabolites produced by Actinobacteria and Streptomyces spp. These metabolites, which include polyphenols, indolocarbazoles, anthracyclines, halogenated compounds, polyketides, anthracenes, and alkaloids, form the foundation of traditional chemotherapy drugs like doxorubicin, mithramycin, and mitomycin C ( 86 ).…”
Section: Plant Medicine: the Plant Microbiomementioning
confidence: 99%
“…The oxazolidinones, which are five‐membered heterocyclic compounds, form a novel category of antibacterial medications characterized by their unique structures and potent efficacy against gram‐positive pathogenic bacteria, such as penicillin‐resistant streptococci, methicillin‐resistant Staphylococcus aureus (MRSA), and vancomycin‐resistant enterococci [1] . Oxazolidinones also gained significant attention a few years ago due to the imminent release of the linezolid drug, which is used to treat tuberculosis [2] .…”
Section: Introductionmentioning
confidence: 99%